When superbug infections spread across hospitals, scientists are often left puzzled at how the pathogens spread. A new paper suggests its down to genetics.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
The FDA has warned that it will be coming down hard on anyone carrying out do-it-yourself gene therapy, in a recent statement.
GlaxoSmith Kline (GSK) has welcomed the news that two of its drug regimen to treat HIV have won US approval, with its Juluca treatment.
Pfizer has found itself in a battle with several states who are intending to use some of its drugs to carry out executions.
One under the radar biotech could be trumping all its competitors, after it makes significant progress in potentially producing an Alzheimer’s treatment.
This Thanksgiving investors are thankful that the S&P 500 is up about 15% year to date, with that path expected to continue to the end of the year.
Before launching an offshore herpes vaccine trial, an American researcher conducted unregulated human herpes experiments in hotels near the college campus.
A team of scientists has come up with a novel approach to block the transfer of resistance genes.
With more money being plugged into battling antibiotic resistance, researchers have begun to consider synthetic biology as a new way to fight bacteria.
Moderna Therapeutics has began taking the steps to produce a cancer vaccine based on the growing volume of research on messenger RNA (mRNA).
The two FDA-approved manufacturers of the vaccine, hit by an unexpected spike in demand, have had difficulty keeping pace.